/* Google Analytics Code asynchronous */

Wednesday, October 22, 2008

Drug Industry - Premptive Moves?

THEY JUST MOVED HILLARY'S STARTING LINE

Merck announced a multi-year round of massive cost restructuring, 40% reportedly centered on reductions and changes in the sales force.

The moves are anticipated by many observers to be at the leading edge of what other companies will also announce.

Anyway, the worst stories about how drugs are sold ... can now be dismissed as 'in the past', perhaps.

This may make it harder to get a Canadian-style Drug Pricing Transparency board set-up in the U.S. (and really, a little transparency can go a long way, even if you need a stick for the 'hard cases').